Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Pfizer
With
JANSSEN Alzheimer Immunotherapy Research & Development, LLC
Age
50–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Concern about a change in cognition expressed by the subject or by an informant that knows the subject well
Mini-Mental State Examination (MMSE) score ≥ 25
Global Clinical Dementia Rating = 0.5.
General cognition and functional performance sufficiently preserved such that a diagnosis of Alzheimer's dementia cannot not be made by the site physician at the time of screening.
Amyloid burden detected on screening brain PET scan.
You may not be if
Significant neurological disease other than early Alzheimer's disease
Major psychiatric disorder or symptom
Contraindication to undergo brain MRI
Unstable medical conditions
Clareo Health | Amyloid Imaging And Safety Study Of ACC-001 In Subjects With Early Alzheimer's Disease
